$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Dec 9, 2025)
$1.01B
Market Cap
-
P/E Ratio
-1.27
EPS
$30.35
52 Week High
$2.82
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Nanobiotix SA is a pioneering clinical-stage biotechnology company based in Paris, France, specializing in the development of groundbreaking cancer therapies utilizing its proprietary nanotechnology platform. Committed to improving treatment efficacy and minimizing side effects, the company is advancing a robust pipeline of localized therapies across multiple clinical trial stages. With its innovative approach and strategic partnerships, Nanobiotix is poised to redefine oncology treatment paradigms and enhance patient outcomes on a global scale, positioning itself as a significant player in the fight against cancer.
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG
LPTX
NVDA
WBD
ASST
VHAI
PLUG
BYND
AAL
TSLA
INTC
SOFI
CFLT
NFLX
ADAP
GRAB
BITF
BAC
PFE
MARA
T
DNN
KVUE
IRBT
WULF
CIFR
F
CLSK
KEY
VZ
APLD
HPE
RGTI
CXAI
IREN
GOOGL
HBAN
NIO
BTBT
MTSR
DVLT
RIG
AMD
RR
SOUN
MSTR
XOM
AVGO
SNAP
WMT
MRVL
VALE
QBTS
KDP
CAN
ITUB
SLM
NVTS
AGNC
NCLH
HOOD
PCG